Crossmark

Reversal of cerebral hypoperfusion: a novel therapeutic target for the treatment of AD/ADRD?

Published Online: 2021-03-27

Published Print: 2021-04

Authors

Fan, Fan https://orcid.org/0000-0003-1463-3610
Roman, Richard J.
Funding

Funding for this research was provided by:

National Institutes of Health (AG050049)

National Institutes of Health (AG057842)

National Institutes of Health (P20GM104357)

National Institutes of Health (P20GM104357)

National Institutes of Health (HL138685)
License Information

Text and Data Mining valid from 2021-03-27

Version of Record valid from 2021-03-27
More Information

Article History

Received: 11 March 2021

Accepted: 15 March 2021

First Online: 27 March 2021

Declarations

:

: The authors declare no competing interests.

Document is current